England - London • Public sector

Fieldfisher

More informationMore information

The team at Fieldfisher advises a varied client base of care providers and employers on regulatory issues. A particular recent highlight involves assisting the Covid-19 inquiry with its set-up and establishment. Sarah Ellson leads the team with her vast expertise in regulatory issues surrounding cannabis and CBD, regularly advising medical manufacturers, online pharmacies, and clinicians. Known for his corporate and commercial expertise, Neil Palmer assists GPs and independent providers of NHS services with M&A deals and commercial contracts.

Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • 'Detail-oriented and very pragmatic.'
  • 'Firm is supportive and pro-active.'

Key clients

  • Novartis Pharma AG
  • MBI Technology
  • Fresenius Kabi Ltd
  • City Healthcare Partnership CIC
  • Optima Health Group Limited
  • Human Fertilisation and Embryology Authority
  • Rowlands Pharmacies
  • Phoenix Healthcare
  • Human Tissue Authority
  • Roche Products

Work highlights

  • Assisting Novartis Pharma with identifying the local regulations and legislation in relation to patient support programmes in over 38 countries.
  • Defending the Human Fertilisation and Embryology Authority in ongoing judicial review proceedings in relation to the advice the HFEA provides on add-on treatments.
  • Assisting the UK Covid-19 inquiry with its set-up and establishment.

Lawyers

Leading individuals

Practice head

The lawyer(s) leading their teams.

Sarah Ellson

Other key lawyers

Neil Palmer, Janita Good